Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration

Kung,Chang-I; Chen,Cheng-Yi; Yang,Chih-Chang; Lin,Cheng-Yu; Chen,Tien-Hua; Wang,Hwai-Shi

doi:10.3892/or.2012.1993

Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration

Authors:
- Chang-I Kung
- Cheng-Yi Chen
- Chih-Chang Yang
- Cheng-Yu Lin
- Tien-Hua Chen
- Hwai-Shi Wang
View Affiliations

Affiliations: Institute of Anatomy and Cell Biology, School of Medicine, National Yang Ming University, Taipei, Taiwan, R.O.C. , Department of Surgery, Veterans General Hospital, Taipei, Taiwan, R.O.C.
Published online on: August 24, 2012 https://doi.org/10.3892/or.2012.1993
Pages: 1808-1814

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hyaluronan (HA), a component of the extracellular matrix, plays an important role in cell-cell adhesion and cell migration. Membrane type 1-matrix metalloproteinase (MT1‑MMP) is often expressed in invasive cancer cells. CD44, a transmembrane receptor for HA, is implicated in various adhesion-dependent cellular processes including cell migration, tumor cell metastasis and invasion. Previous studies have shown that CD44 is highly expressed in cancer cells and may be proteolytically cleaved at the ectodomain by MT1-MMP; this process of inducing CD44 cleavage plays a critical role in cancer cell migration. We hypothesized that HA modulates MT1-MMP expression to facilitate breast cancer cell migration. Flow cytometry, real-time PCR, western blotting and immunofluorescence staining were used to quantify HA-induced MT1-MMP expression in breast cancer cells. In order to validate the relevance of cell migration and HA-induced MT1-MMP, we analyzed the cell migration via matrigel-coated transwell. We found that after HA oligosaccharide (6.5 kDA) stimulation, MT1-MMP expression in the membrane of breast cancer cells was increased. In response to HA oligosaccharide stimulation, significant upregulation of MT1-MMP mRNA occurred. Our data also provide evidence that HA oligosaccharide enhances MT1-MMP; the elevated expression of MT1-MMP confers enhanced CD44 cleavage and cell migration. In conclusion, we have identified a new function of HA in the induction of MT1-MMP expression in breast cancer cell lines and CD44 cleavage to increase cell migration during the invasion process. The HA oligosaccharide-induced MT1-MMP expression in breast cancer cells may be a critical step in the formation of metastatic colonies.

View Figures

View References

1	Lesley L, Hyman R and Kincade PW: CD44 and its interaction with extracellular matrix. Adv Immunol. 54:271–335. 1993. View Article : Google Scholar : PubMed/NCBI
2	Naor D, Sionov RV and Ish-Shalom D: CD44: structure, function, and association with the malignant process. Adv Cancer Res. 71:241–319. 1997. View Article : Google Scholar : PubMed/NCBI
3	Shimizu Y, Van Seventer GA, Siraganian R, et al: Dual role of the CD44 molecule in T cell adhesion and activation. J Immunol. 143:2457–2463. 1989.PubMed/NCBI
4	Gunthert U, Hofmann M, Rudy W, et al: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 65:13–24. 1991. View Article : Google Scholar : PubMed/NCBI
5	Screaton GR, Bell MV, Jackson DG, et al: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA. 89:12160–12164. 1992. View Article : Google Scholar : PubMed/NCBI
6	Underhill CB: CD44: the hyaluronan receptor. J Cell Sci. 103:293–298. 1992.
7	Liotta LA: Tumor invasion and metastases - role of the extracellular matrix: Rhoads Memorial Award Lecture. Cancer Res. 46:1–7. 1986.PubMed/NCBI
8	Guo UJ, Ma J, Wang J, et al: Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res. 54:1561–1565. 1994.PubMed/NCBI
9	Zahalka MA, Okon E, Gosslar U, et al: Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent. J Immunol. 154:5345–5355. 1995.PubMed/NCBI
10	Okamoto I, Kawano Y, Tsuiki H, et al: CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration. Oncogene. 18:1435–1446. 1999. View Article : Google Scholar : PubMed/NCBI
11	Zhong J, Cornelsen Gencay MM, Bubendorf L, et al: ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells. J Cell Physiol. 207:540–552. 2006. View Article : Google Scholar : PubMed/NCBI
12	Okamoto I, Kawano Y, Murakami D, et al: Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J Cell Biol. 155:755–762. 2001. View Article : Google Scholar : PubMed/NCBI
13	Mignatti P and Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev. 73:161–195. 1993.PubMed/NCBI
14	Nagase H and Woessner JF Jr: Matrix metalloproteinases. J Biol Chem. 274:21491–21494. 1999. View Article : Google Scholar
15	Seiki M: Membrane-type matrix metalloproteinases. APMIS. 107:137–143. 1999. View Article : Google Scholar
16	Hiraoka N, Allen E, Apel IJ, et al: Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell. 95:365–377. 1998. View Article : Google Scholar : PubMed/NCBI
17	Galvez BG, Matias-Roman S, Albar JP, et al: Membrane type 1-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling. J Biol Chem. 276:37491–37500. 2001. View Article : Google Scholar
18	Egeblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2:161–174. 2002. View Article : Google Scholar : PubMed/NCBI
19	Sato H, Takino T, Okada Y, et al: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 370:61–65. 1994. View Article : Google Scholar : PubMed/NCBI
20	Knauper V, Will H, Lopez-Otin C, et al: Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem. 271:17124–17131. 1996. View Article : Google Scholar : PubMed/NCBI
21	Kuo YC, Su CH, Liu CY, et al: Transforming growth factor-beta induces CD44 cleavage that promotes migration of MDA-MB-435s cells through the up-regulation of membrane type 1-matrix metalloproteinase. Int J Cancer. 124:2568–2576. 2009. View Article : Google Scholar : PubMed/NCBI
22	Seiki M: The cell surface: the stage for matrix metalloproteinase regulation of migration. Curr Opin Cell Biol. 14:624–632. 2002. View Article : Google Scholar : PubMed/NCBI
23	Okada Y: Tumor cell-matrix interaction: pericellular matrix degradation and metastasis. Verh Dtsch Ges Pathol. 84:33–42. 2000.PubMed/NCBI
24	Laurent TC and Graser JR: Hyaluronan. FASEB J. 6:2397–2404. 1992.PubMed/NCBI
25	Balazs EA, Watson D, Duff IF, et al: Hyaluronic acid in synovial fluid. I Molecular parameters of hyaluronic acid in normal and arthritis human fluids. Arthritis Rheum. 10:357–376. 1967. View Article : Google Scholar : PubMed/NCBI
26	Dahl IM and Laurent TC: Concentration of hyaluronan in the serum of untreated cancer patients with special reference to patients with mesothelioma. Cancer. 62:326–330. 1988. View Article : Google Scholar : PubMed/NCBI
27	Kumar S, West DC, Ponting JM, et al: Sera of children with renal tumours contain low-molecular-mass hyaluronic acid. Int J Cancer. 44:445–448. 1989. View Article : Google Scholar : PubMed/NCBI
28	Lokeshwar VB, Obek C, Soloway MS, et al: Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer. Cancer Res. 57:773–777. 1997.PubMed/NCBI
29	West DC, Hampson IN, Arnold F, et al: The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Science. 228:1324–1326. 1985.
30	Lokeshwar VB, Rubinowicz D, Schroeder GL, et al: Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer. J Biol Chem. 276:11922–11932. 2001. View Article : Google Scholar : PubMed/NCBI
31	Pham JT, Blick NL and Lokeshwar VB: Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer. Cancer Res. 57:778–783. 1997.PubMed/NCBI
32	Itano N, Atsumi F, Sawai T, et al: Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration. Proc Natl Acad Sci USA. 99:3609–3614. 2002. View Article : Google Scholar : PubMed/NCBI
33	Sohara Y, Ishiguro N, Machida K, et al: Hyaluronan activates cell motility of v-Src-transformed cells via Ras-mitogen-activated protein kinase and phosphoinositide 3-kinase-Akt in a tumor-specific manner. Mol Biol Cell. 12:1850–1868. 2001. View Article : Google Scholar : PubMed/NCBI
34	Sneath RJ and Mangham DC: The normal structure and function of CD44 and its role in neoplasia. Mol Pathol. 51:191–200. 1998. View Article : Google Scholar : PubMed/NCBI
35	Kajita M, Itoh Y, Chiba T, et al: Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol. 153:893–904. 2001. View Article : Google Scholar : PubMed/NCBI
36	Mori H, Tomari T, Koshikawa N, et al: CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. EMBO J. 21:3949–3959. 2002. View Article : Google Scholar : PubMed/NCBI
37	Ueda J, Kajita M, Suenaga N, et al: Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors. Oncogene. 22:8716–8722. 2003. View Article : Google Scholar : PubMed/NCBI
38	Annabi B, Bouzeghrane M, Moumdjian R, et al: Probing the infiltrating character of brain tumors: inhibition of RhoA/ROK-mediated CD44 cell surface shedding from glioma cells by the green tea catechin EGCg. J Neurochem. 94:906–916. 2005. View Article : Google Scholar : PubMed/NCBI
39	Goebeler M, Kaufmann D, Brocker EB, et al: Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors. J Cell Sci. 109:1957–1964. 1996.PubMed/NCBI
40	Hotary K, Allen E, Punturieri A, et al: Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol. 149:1309–1323. 2000. View Article : Google Scholar : PubMed/NCBI
41	Iida N and Bourguignon LY: New CD44 splice variants associated with human breast cancers. J Cell Physiol. 162:127–133. 1995. View Article : Google Scholar : PubMed/NCBI